Story thread · 5 reports / 3 sources
Novo Nordisk launches weekly insulin in the US
cphpost.dk · 10h
How the coverage leans
Across 3 sources · syndicated copies counted once
The Danish pharmaceutical company Novo Nordisk is launching the drug Awiqli, intended for people with type 2 diabetes, in the US, the company announced in a press release Tuesday afternoon. Compared to other types of insulin, Awiqli only needs to be injected once a week, whereas traditional insulins typically require one or more daily injections. […]
First report: Insider trades: Microsoft, Meta, Pfizer among notable names — seekingalpha.com, 3d
The coverage
- Novo Nordisk and AWS bring agentic AI into drug discovery
artificialintelligence-news.com · 14h
The conversation · 0
Sign in to join the conversation.
No comments yet — start the thread.